EURARTESIM

This brand name is authorized in Austria, Croatia, Cyprus, Estonia, France, Ireland, Lithuania, Netherlands, Poland, Spain, UK.

Active ingredients

The drug EURARTESIM contains a combination of these active pharmaceutical ingredients (APIs):

1	Piperaquine tetraphosphate (as tetrahydrate) UNII 854D7K8LXB - PIPERAQUINE PHOSPHATE
	Read more about
2	Dihydroartemisinin (DHA) UNII 6A9O50735X - ARTENIMOL
	Artenimol is an artemisinin derivative and antimalarial agent used in the treatment of uncomplicated Plasmodium falciparum infections. Artemisinin combination therapy is highly effective against malaria.
	Read more about Artenimol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EURARTESIM Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P01BF05	Artenimol and piperaquine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1546703, 1546714, 1546725, 1546736, 1546747
ES	Centro de información online de medicamentos de la AEMPS	11716004
FR	Base de données publique des médicaments	62434676
GB	Medicines & Healthcare Products Regulatory Agency	209326
IE	Health Products Regulatory Authority	15081
LT	Valstybinė vaistų kontrolės tarnyba	1063109, 1063110, 1063111, 1063112, 1063113, 1093284, 1093285
NL	Z-Index G-Standaard, PRK	102067
PL	Rejestru Produktów Leczniczych	100309651, 100309668